McMichael Bryan J 4

What Happened Bryan J. McMichael, Chief Financial Officer of Coherus Oncology (CHRS), had 1,715 shares withheld to cover tax liability in connection with the vesting of restricted stock units. The withholding was recorded at $1.55 per share for a total value of $2,658. This was a tax-withholding disposition (code F), not an open-market sale by the reporting person.

Key Details

• Transaction date: 2026-01-20; Form 4 filed: 2026-01-22 (timely).
• Shares withheld/disposed: 1,715 shares at $1.55 each; total value ~$2,658.
• Transaction code: F (shares withheld to satisfy tax withholding on RSU vesting).
• Footnote: F1 states shares were automatically withheld by the issuer to pay tax liability; no shares were sold by the reporting person.
• Shares owned after transaction: not disclosed in the filing.

Context This is a routine tax-withholding event tied to RSU vesting and does not represent an open-market sale or purchase. Such withholdings are administrative and typically do not signal insider buying or selling intent.